₹143.90
+₹0.00 (+0.00%)
Closed · As of 26 Aug 3:30 pm
Mkt Cap
₹121 Cr
P/E
-2055.71
ROE
3.15%
ROCE
3.39%
About iSERA Lifesciences Ltd
Covidh Technologies domain and technology expertise has been built over last 5 years through a unique combination of long standing customer relationships, investments in people and through continuous investments in new technologies.
Founded
1993
CEO
N/A
Employees
0
HQ
Mumbai, India
About iSERA Lifesciences Ltd
Covidh Technologies domain and technology expertise has been built over last 5 years through a unique combination of long standing customer relationships, investments in people and through continuous investments in new technologies.
Founded:1993
CEO:N/A
Employees:0
HQ:Mumbai, India
Finished Products
No finished products reported
This company hasn’t disclosed any finished products breakdown.
Raw Materials
No raw materials reported
This company hasn’t disclosed any raw materials breakdown.
Price Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹144
52W Low
₹5
Volume10
Avg VolumeN/A
Beta0.09
Dividend Yield0.00%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
-2055.71x
Valuation
P/B Ratio
14.67x
Valuation
EPS
₹-0.07
Valuation
Dividend Yield
0.00%
Valuation
ROE
3.15%
Profitability
ROCE
3.39%
Profitability
Revenue by Segment
Contribution & growth by business line
IT/ITESRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
0.0%
International
0.0%
No geographic split data available
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.20x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
0.2%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.